FdaApplication

ANDA 076135

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTEVA PHARMACEUTICALS USA
application_typeANDA
approval_date2003-04-11

Products (3)

ProductActive ingredientStrengthDosage form
CLARAVISISOTRETINOIN20MGCAPSULE;ORAL
CLARAVISISOTRETINOIN30MGCAPSULE;ORAL
CLARAVISISOTRETINOIN40MGCAPSULE;ORAL

3 products